AAAAAA
Results:
1-7
|
Results: 7
Authors:
Vredenburg, MR
Ojima, I
Veith, J
Pera, P
Kee, K
Cabral, F
Sharma, A
Kanter, P
Greco, WR
Bernacki, RJ
Citation: Mr. Vredenburg et al., Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance, J NAT CANC, 93(16), 2001, pp. 1234-1245
Authors:
Chibale, K
Ojima, I
Haupt, H
Geng, XG
Pera, P
Bernacki, RJ
Citation: K. Chibale et al., Modulation of human mammary cell sensitivity to paclitaxel by new quinoline sulfonamides, BIOORG MED, 11(18), 2001, pp. 2457-2460
Authors:
Gruol, DJ
Bernd, J
Phippard, AE
Ojima, I
Bernacki, RJ
Citation: Dj. Gruol et al., The use of a novel taxane-based P-glycoprotein inhibitor to identify mutations that alter the interaction of the protein with paclitaxel, MOLEC PHARM, 60(1), 2001, pp. 104-113
Authors:
Ojima, I
Lin, SN
Slater, JC
Wang, T
Pera, P
Bernacki, RJ
Ferlini, C
Scambia, G
Citation: I. Ojima et al., Syntheses and biological activity of C-3 '-difluoromethyl-taxoids, BIO MED CH, 8(7), 2000, pp. 1619-1628
Authors:
Ojima, I
Wang, T
Miller, ML
Lin, SN
Borella, CP
Geng, XD
Pera, P
Bernacki, RJ
Citation: I. Ojima et al., Synthesis and structure-activity relationships of new second-generation taxoids, BIOORG MED, 9(24), 1999, pp. 3423-3428
Authors:
Dimitroff, CJ
Klohs, W
Sharma, A
Pera, P
Driscoll, D
Veith, J
Steinkampf, R
Schroeder, M
Klutchko, S
Sumlin, A
Henderson, B
Dougherty, TJ
Bernacki, RJ
Citation: Cj. Dimitroff et al., Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: Implications for combination treatment with photodynamic therapy, INV NEW DR, 17(2), 1999, pp. 121-135
Authors:
Dimitroff, CJ
Pera, P
Dall'Olio, F
Matta, KL
Chandrasekaran, EV
Lau, JTY
Bernacki, RJ
Citation: Cj. Dimitroff et al., Cell surface N-acetylneuraminic acid alpha 2,3-galactoside-dependent intercellular adhesion of human colon cancer cells, BIOC BIOP R, 256(3), 1999, pp. 631-636
Risultati:
1-7
|